February 2018 in “The American Journal of Gastroenterology” This study observed that intravenous ferric carboxymaltose did not inhibit the drug-induced reduction of inflammatory activity in patients with inflammatory bowel disease, as indicated by lower CRP levels.
January 2018 in “Journal of Crohn s and Colitis” This study found that high-dose intravenous ferric carboxymaltose may reduce inflammatory activity in patients with inflammatory bowel disease and iron deficiency anaemia, as evidenced by decreased CRP levels and improved clinical disease indices.
July 2021 in “Clinical Medicine” This article discusses the diagnosis and management of iron deficiency without anemia, but reports no new results; comments on dermatological aspects are also included.
January 2015 in “Iraqi Journal of Hematology” In this study, oral iron replacement therapy showed improvement in hair loss severity for some women with low serum ferritin levels, but not all responded.
In this study, oral iron replacement showed some evidence of improving chronic telogen effluvium in iron deficient women, though further research is required to confirm the association.